Orgenesis, a company involved in the emerging fields of cellular therapy and regenerative medicine, has received a patent for the technology supporting its unique cell-based therapy, which is being developed as a potential cure for Type 1 Diabetes, it was reported yesterday.
The anaylst expects that the use of autologous mesenchymal stem cell-derived and human embryonic stem cell derived cardiomyocytes and endothelial cells represent future trend in development of stem cell-based therapy for cardiac diseases.
MPI Research, a preclinical contract research organization that sponsors annual educational summits, is proud to present, Advances in Therapeutic Discovery and Drug Development: Preclinical Cell-Based Therapy Research, August 15-17, 2007 at the historic and picturesque Brook Lodge in Augusta, Michigan.
He will discuss these platforms developed by the company's subsidiaries, PrimeCell[TM] Therapeutics LLC and NewStem Biosciences LLC, including pre-clinical work using cell-based therapy to treat spinal cord injury.
AGS-003 is a second-generation dendritic cell-based therapy with optimized immune response characteristics that is designed to stimulate the patient's immune system to target and destroy the patient's cancer cells.
NASDAQ:CYTX) (Frankfurt:XMPA) announced today preclinical data demonstrating that adipose stem and regenerative cell-based therapy following a heart attack in pigs is not associated with an increased risk of irregular heart rhythms, which can result in potentially life threatening complications from heart attacks.